Health Care & Life Sciences » Pharmaceuticals | Hubei Jumpcan Pharmaceutical Co. Ltd.

Hubei Jumpcan Pharmaceutical Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
403
519
683
934
1,224
1,688
Depreciation, Depletion & Amortization
67
86
112
118
154
178
Other Funds
16
635
1
628
24
67
Funds from Operations
486
612
806
1,061
1,398
1,966
Changes in Working Capital
196
11
151
140
202
232
Net Operating Cash Flow
289
622
656
922
1,196
1,734
Capital Expenditures
270
302
396
323
746
Sale of Fixed Assets & Businesses
-
-
1
6
1
Purchase/Sale of Investments
5
359
150
126
462
Net Investing Cash Flow
263
660
436
403
1,328
Cash Dividends Paid - Total
-
38
313
547
591
Issuance/Reduction of Debt, Net
27
20
280
-
-
Net Financing Cash Flow
11
617
594
81
213
Net Change in Cash
37
579
374
600
81
Free Cash Flow
19
321
260
598
450
Deferred Taxes & Investment Tax Credit
1
3
2
4
5
34
Net Assets from Acquisitions
-
-
190
-
153
Other Sources
10
-
-
40
32
Change in Capital Stock
-
-
-
-
15

About Hubei Jumpcan Pharmaceutical Co.

View Profile
Address
Baota Bay
Taizhou Jiangsu 225441
China
Employees -
Website -
Updated 07/08/2019
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the drug research and development, production, and sale. Its product covers pediatrics, breathing, and digestion field. Its product focuses on anti-inflammatory oral solution, enteric-coated capsules, and children fever particles.